Apnea, bradycardia, and oxygen desaturation events are a common in neonatal intensive care units, with relevant literature to date largely focusing on very low birth weight and extremely low birth weight infants. We conducted a retrospective review of infants born at ≥34 weeks gestational age at 2 tertiary neonatal intensive care units in Boston, MA, between January 2009 and December 2013. Our objectives included (1) describing the diagnostic evaluations performed in late preterm to term infants with discharge-delaying apnea, bradycardia, or oxygen desaturation events and (2) identifying variables associated with home monitor use. Of the 741 eligible infants identified, diagnostic evaluations were variable and infrequent with blood culture, blood glucose, and head ultrasound performed most commonly. The likelihood of home monitor use was greater in infants with either a prolonged inpatient stay or greater gestational age at birth.
Introduction
Apnea, bradycardia, and oxygen desaturation (ABD) events are a common in neonatal intensive care units (NICUs), with relevant literature to date largely focusing on very low birth weight and extremely low birth weight infants. [1] [2] [3] [4] [5] [6] Studies describing the incidence of ABD events in late preterm infants are limited, with estimates ranging from 0.9% to over 25%. [7] [8] [9] [10] [11] According to National Vital Statistics Reports, in 2013 there were 3.93 million births in the United States, of which 7.99%, or just over 314 000, were late preterm. 12 The incidence of ABD events in term infants is even less well described. Though the incidence of ABD events in late preterm to term infants may be relatively low, the absolute number of affected infants is significant.
The diagnostic evaluation of ABD events is likely variable, though has received little attention in the literature. Furthermore, management guidelines for affected late preterm to term infants with ABD events are similarly inconsistent and may not necessarily be extrapolated from available practice patterns pertaining to lower birth weight infants. 3, [13] [14] [15] Assuming an accurate diagnosis of ABD events, some "margin of safety," or ABD event-free period before discharge, has become the standard of care. 3, 13 One practice pattern that has emerged, as an alternative to inpatient observation pending a predetermined ABD eventfree period, includes discharge home with a monitor that is subsequently discontinued as an outpatient when cardiorespiratory maturity has been reached. 3, 6, [13] [14] [15] However, standardized, evidence-based selection of candidates for home monitoring has been inadequately described, and the safety, efficacy, and cost-effectiveness of home monitor use remains incompletely understood.
The aims of our study were (1) to describe the diagnostic evaluations performed in a cohort of late preterm to term infants who experienced an ABD event as the last discharge-delaying diagnosis and (2) to characterize the subset of infants discharged with a home monitor.
Methods

Study Population
All eligible infants with a discharge-delaying ABD event were born at gestational age (GA) ≥34 0/7 weeks with a documented event within 6 days of NICU discharge at 2 large tertiary care delivery hospitals in Boston (Beth Israel Deaconess Medical Center [BIDMC] and Brigham and Women's Hospital [BWH]) between January 1, 2009, and December 31, 2013. A maximum period of 6 days was chosen in consideration of a 5-day event count, which historically has been the standard margin of safety utilized at these institutions. GA at both institutions was ascertained via first trimester ultrasound when available or otherwise via date of last menstrual period as noted in maternal admission documentation. Both institutions throughout the study period required direct admission to the NICU for GA at birth of <36 weeks with continuous pulse oximetry standard on admission.
At BWH, we identified all infants born at GA ≥34 0/7 weeks with ICD-9 codes for "Apnea," "Cyanotic attack," or "Hypoxemia," at any point in the NICU hospitalization. At BIDMC, we identified all infants born at GA ≥34 0/7 weeks with an ABD recorded in the electronic medical record ≤6 days prior to discharge date. Patient-level chart manual review was subsequently conducted for all identified infants to confirm eligibility. Infants were excluded for (1) inaccurately assigned diagnosis code, (2) GA <34 weeks, (3) ABD event count <3 days suggesting perceived clinical insignificance of ABD events, (4) insufficient medical record data, (5) failure to tolerate full oral feeds at least 2 days prior to NICU discharge, (6) indication for hospitalization other than ABD events within 2 days of NICU discharge, or (7) presence of a significant comorbidity that could play a contributing role in the pathogenesis of ABD events. Examples of comorbidities that led to exclusion included chromosomal abnormalities, anatomic abnormalities of the face or airway, sepsis, necrotizing enterocolitis, intraventricular hemorrhage, seizure, and cyanotic congenital heart disease. In order to be significant for our analysis, a cardiorespiratory event had to occur outside of the delivery room and trigger a resolution-monitoring period or ABD event count of at least 5 days. To ensure that solely ABD events prolonged an infant's length of stay, we noted lack of maturation in other areas of development past an infant's last ABD event date. As an example, if an infant's feeding regimen included nutrition through nonoral routes (gavage or parenteral) 2 days or fewer before discharge, it was determined that feeding behavior was delaying discharge, and the infant was therefore excluded.
Data Collection
Information extracted from infants' NICU discharge summaries, and corroborated through review of NICU daily progress notes, included demographics (measurements, GA, sex, race, multiple gestation, caesarean section or vaginal delivery, and birth hospital), and maternal medical information. The uses of respiratory support, caffeine, surfactant, and reflux medications were recorded. Additionally, date and circumstances of the last ABD event were recorded. Timing of any diagnostic testing, including blood glucose levels, electroencephalogram (EEG), head imaging, electrocardiogram (EKG), echocardiogram, blood culture, lumbar puncture, and gastroesophageal reflux studies were also extracted. Select charts were reviewed by secondary study personnel to assure accuracy of data extraction.
All aspects of this study were reviewed and approved by the institutional review boards of Boston Children's Hospital, Beth Israel Deaconess Medical Center, and Partners Healthcare.
Data Analysis
Analysis was stratified by study center, GA at birth, and home monitor use at the time of NICU discharge. Statistical differences between groups were assessed using χ 2 tests or Fisher exact tests for categorical variables and t tests or Kruskal-Wallis tests for continuous variables. A P value <.05 was considered statistically significant. All analyses were performed using SAS 9.3.
Results
In total, we identified 741 eligible late preterm to term infants with discharge-delaying ABD events during our 5-year study period ( Figure 1 ). Infants entered into our cohort via 3 distinct clinical scenarios: (1) term infants with a witnessed ABD event in the Newborn Nursery or at home shortly after discharge, (2) infants who failed an Infant Car Seat Challenge who were then noted to have persistence of ABD events in a Car Bed Challenge, and (3) infants admitted exclusively for prematurity (birth GA <36 0/7 weeks) who were then noted on monitoring to have ABD events.
Clinical characteristics of infants stratified by center demonstrated a few distinctions. Infants born at Center A were more likely to be diagnosed with an ABD event, were of slightly larger birth weight, were less likely to receive an extensive workup, and were of slightly older corrected gestational age (CGA) at the time of discharge (Tables 1 and 2) .
Diagnostic workup of ABD events in our cohort was limited. The most common diagnostic evaluations performed included blood culture, blood glucose, and head ultrasound. Both blood culture and blood glucose evaluation were most often incorporated into the admission evaluation of premature infants and not specific to the workup of ABD events. Cardiac, neurologic, and gastrointestinal studies were relatively uncommon ( Table 2) .
Restricting analysis to Center B, the only center noted to utilize home monitoring during our study period, infants discharged on a home monitor were more likely to have been evaluated via a pneumogram (encompassing heart rate, pulse oximetry, nasal air flow, and respiratory effort evaluation), EKG, EEG, head ultrasound, brain magnetic resonance imaging (MRI), and impedance study (pH-independent reflux evaluation via multichannel intra-esophageal measurement of electrical resistance). Similar rates of echocardiogram and upper gastrointestinal series were noted. No infants in either group underwent head computed tomography (Table 3) .
When comparing late preterm to term infants, nearly all diagnostic evaluations, with the exception of blood culture, blood glucose, and upper gastrointestinal series, occurred significantly more often in the full-term population (Table 4 ).
Regarding the timing of diagnostic evaluation, late preterm infants were the subject of testing in the later stages of hospitalization in contrast to term infant's whose diagnostic evaluation was more likely to be extensive and clustered in the first 7 days of NICU admission. Correcting for GA at the time of evaluation, diagnostic workups for ABD events universally occurred at 37 to 41 weeks CGA.
The subset of our cohort that was discharged on a home monitor was 4.5% and included only infants born at Center B. Of infants born at Center B, 10.4% were discharged home with a monitor. Infants discharged with a home monitor were of significantly greater GA at birth. Specifically, GA at birth of infants discharged with a home monitor ranged from 34 0/7 to 40 6/7 weeks gestation with an interquartile range of 35.4 to 38.6 weeks gestation. Restricting analysis to Center B, there were no group differences with regard to gender, race, birth weight, or mode of delivery (Table 5) .
During hospitalization, infants discharged home with a monitor were more likely to have been treated with caffeine and reflux medication, were of significantly greater CGA at the time of achievement of full oral feeds, and had a significantly longer length of stay after achievement of full oral feeds. At discharge, infants in the home monitor group had a longer length of stay, were more likely to have been sent home with caffeine, had a greater mean discharge weight, and were of significantly greater CGA (Table 6) .
No specific policies pertaining to home monitor use and no relevant policy changes were noted at either institution during the 5-year study period. However, the last year of our study period, 2013, accounted for over half of infants discharged home with a monitor (19/33; Table 7 ).
The most common discharge-delaying ABD event was oxygen desaturation (61%). Documentation of apnea, bradycardia, and desaturation co-occurrence was rare with 2.6% and 13.3% of events noted as such at Center A and Center B, respectively.
Discussion
Few infants in our study population of late preterm to term infants received an extensive diagnostic workup for ABD events. The overwhelming majority of infants were subject to glucose testing and blood culture screening reflecting routine NICU practice irrespective of ABD occurrence. Of infants discharged home with a monitor, the majority (67.6%) were evaluated via a pneumogram. Though available literature is lacking regarding the use of a pneumogram as a predictive tool for sudden infant death syndrome, limited data do support the potential use of a pneumogram for documentation of ABD event resolution with caffeine treatment. [16] [17] [18] Information pertaining to the clinical utility of other diagnostic studies in the setting of ABD events is less clear. Infants in our study discharged without a monitor were rarely the subject of testing beyond blood culture and blood glucose, while infants discharged with a home monitor were more likely to have been evaluated via a pneumogram, EKG, EEG, head ultrasound, MRI, and impedance testing, suggesting a practice trend toward formal diagnostic testing to exclude alternate etiologies for ABD events in the home monitor group. Still, this practice trend was inconsistent as only a minority of infants discharged with a monitor were the subject of EKG, EEG, lumbar puncture, MRI, and impedance testing. That few diagnostic studies were performed in our cohort is indicative of either perceived low pretest probability, with presumed clinical confidence in the diagnosis of respiratory immaturity, or failure to identify underlying pathology responsible for persistent ABD events.
Clinical confidence in the diagnosis of respiratory immaturity decreased with increasing CGA as evidenced by a greater likelihood for extensive testing. Strictly speaking then, when the term "apnea of prematurity" could no longer be appropriately utilized, providers were more inclined to seek an alternate etiology for ABD events. Accordingly, the term "apnea of immaturity" may be a more befitting descriptor for the presence of ABD events in a term-corrected population barring the presence of any discernible alternate etiology.
Desaturations were the most commonly documented ABD event, noted in 61% of infants in our study cohort. Rare documentation of apnea, bradycardia, and desaturation co-occurrence (2.6% and 13.3% at each respective institution) may be accounted for by variable sensitivity of apnea monitoring in the setting of short breathing pauses with only desaturation and/or bradycardia alarms triggered. 19 Alternatively, isolated desaturations may be reflective of residual lung disease without associated respiratory drive immaturity. Interestingly though, of the 33 patients discharged home with a monitor 100% had recorded apneic events.
In all, a total of 4.5% of our cohort of late preterm to term infants with ABD events as the last dischargedelaying diagnosis were discharged home with a monitor. While several prior studies make reference to home monitor use in the setting of apnea, 3, 6, [13] [14] [15] our study is distinct in its description of the prevalence of home monitor use in a late preterm to term infant population.
It is remarkable to note that all infants who were discharged home with a monitor were cared for at the same center. This stark contrast in management cannot be attributed to geography or level of care, as both centers are level IIIB NICUs that are located within the Longwood Medical Area of Boston, MA. Recent focus groups conducted with staff at both study locations have confirmed markedly different approaches to the management of ABD events despite a considerable overlap in the training history of staff neonatologists at these institutions (unpublished data). Admittedly though, infants at each institution were identified for inclusion in our study in slightly different fashion with ICD-9 codes versus problem lists screened, introducing potential differential misclassification. Indeed, subtle differences were in fact present between institutions. Still, it is unlikely that such differences could account for 10.4% versus 0% home monitor use (33 vs 0 total infants).
Baseline, discharge characteristics, and hospital course of infants discharged home with a monitor were unique in several aspects. First, infants in the home monitor group were of greater GA at birth and at the time of discharge. Parental and/or provider expectations, in the setting of advanced GA either at birth or at the time of discharge, likely contributed to the selection of home monitor management. Second, treatment with caffeine and gastroesophageal reflux medications during hospitalization and with caffeine at the time of discharge were significantly more likely in the home monitor group, potentially suggesting greater ABD event severity with pharmaceutical attempts at ameliorating ABD events. The potential relationship between gastroesophageal reflux and ABD events remains controversial in earlier preterm infants and its relationship in late preterm to term infants is less well-described, as is the use of caffeine in older infants. [20] [21] [22] [23] Third, infants in the home monitor group had a significantly longer length of stay compared to infants discharged home without a monitor. Intuitively, home monitor use might be expected to shorten length of stay, yet this contradictory finding likely reflects conservative use of home monitors as a management option of last resort. Failure of home monitor use to shorten length of stay has previously been described in a study population of infants born prior to 34 weeks GA. 24 As an aside, it is important to note the absence of data pertaining to significant adverse events associated with home monitor use. A historical exception includes a report of 5 cases of either electrical injury or death with home monitor equipment no longer utilized today. 25 Studies pertaining to the impact of home monitoring on family life have, at the very least, not shown any significant increase in anxiety or depression. [26] [27] [28] [29] The notion of increased parent satisfaction with home monitoring is likely variable and warrants further investigation.
Interestingly, over half of infants (19/33) discharged home with a monitor were born in the last year of our study period, 2013. Moreover, all were born at >37 weeks GA, indicating either a random spike in term infants with ABD events, greater sensitivity for ABD events in the well nursery via direct observation or car seat testing for low birth weight, a random decrease in ABD events in the late preterm population, and/or lower threshold for home monitor use in term infants without an explicit policy change.
Our study was limited by the identification of a few group differences between infants discharged with and without a home monitor. Diagnostic studies were infrequently and variably performed in our study, indicating that individual physician practice rather than consensus guidelines were driving care. Little has thus changed in 20 years since a survey on apnea management sent to neonatology program directors and registered nurses noted variable practice parameters even within a single institution. 30 Our study was additionally restricted to inclusion of 2 local level III academic institutions, thus limiting the generalizability of our findings. Finally, postdischarge data pertaining to duration of home monitor use or adverse events (readmissions, emergency department visits) was not included in our analyses.
Despite its limitations, our study is unique in its description of the diagnostic evaluation and discharge characteristics of late preterm to term infants with discharge-delaying ABD events. Currently, no consensus guidelines exist to inform the diagnostic evaluation of ABD events in this vulnerable population. Moreover, further research is required to determine the role of home monitoring in the management of ABD events, and to better inform patient selection for this approach either in clinical practice or in a future multicenter prospective study. Identification of an at-risk group for a prolonged hospital course secondary to ABD events might serve to shorten length of stay and could significantly affect medical costs as well quality of life for select families.
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